Skip to search formSkip to main contentSkip to account menu

Celontin

Known as: Pfizer brand of methsuximide, Warner-Lambert brand of methsuximide 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

AnticonvulsantsSuccinimidesmethsuximide
Methsuximide:Mass:Pt:Dose:Qnmethsuximide 300 MG Oral Capsule [Celontin]methsuximide Oral Capsule [Celontin]

Narrower (1)

Normethsuximide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1972
1972
Skin eruption from celontin and dilantin.
1972
1972
Skin eruption from celontin and dilantin.
1965
1965
A CASE OF ACCIDENTAL METHSUXIMIDE (CELONTIN) INGESTION.
1965
1965
CROSS-SENSITIVITY TO DILANTIN (DIPHENYLBYDANTOIN) AND CELONTIN (METHSUXIMIDE).
1959
1959
Celontin ‐ a New Anticonvulsant
1. Fifty‐three epileptic patients whose seizures were resistant to numerous anticonvulsant drugs were treated with Celontin. In… 
1959
1959
Treatment of Petit Mal Epilepsy with the New Succinimides: PM 680 and Celontin: (A Clinical Comparative Study)
The newer succinimides PM 680 and celontin have shown a satisfactory effect on petit mal epilepsy. More than 50% of the patients… 
1959
1959
[Experimental and clinical anti-epileptic actions of mepacrine (atebrine), of celontin and of elyptene].
1959
1959
Fatal bone marrow aplasia associated with celontin therapy.
1959
1959
Fatal bone marrow aplasia associated with celontin therapy.
1957
1957
Use of Celontin in the Treatment of Mixed Epilepsy
mg. per kg. of body weight, while mice and rats were completely protected against rtylenetetrazole convulsions by 65 mg. per g… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)